Nabriva Therapeutics AG (NBRV) Financials

$0.40

$-0.05 (-11.11%)

As on 02-Oct-2023 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$38 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-36.71	-59.56	-71.33	-71.89	-72.72
Cash Flow from Investing Activities	--	--	-0.08	-0.27	0.33	-4.60
Cash from Financing Activities	--	1.85	66.37	26.92	56.08	92.92
Net Cash Inflow / Outflow	--	--	--	-44.68	-15.49	15.60

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-163.63	-96.73	-119.14	-98.46	-131.44
ROE (%)	-471.32	-201.91	-114.36	-186.76	-150.61	-152.33
ROA (%)	-91.33	-101.51	-70.97	-91.10	-80.93	-111.34
EBIT Margin (%)	-114.29	-143.47	-178.31	-2,308.87	-1,025.93	-1,763.05
Net Margin (%)	-177.28	-160.33	-181.69	-5,035.07	-1,007.11	-1,765.85
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	17.36	0.31	8.50	-0.63	0.19	0.22
EBIT Growth (%)	4.74	-5.45	26.61	16.81	30.64	-57.07
Net Profit Growth (%)	-44.10	-15.64	28.83	16.05	27.89	-54.37
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.24	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.05	0.13	0.83	0.52	0.65	0.69
Close Price ($)	1.75	1.89	14.97	60.50	330.00	365.00
High Price ($)	10.93	17.77	87.25	412.50	817.50	1,735.00
Low Price ($)	1.22	1.66	12.98	57.75	312.50	280.00
Market Cap ($ Cr)	4.55	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.10	1.59	0.15	0.23	0.84	0.35
Short term debt to equity ratio	1.47	1.47	0.07	0.06	--	--
Current Ratio	1.13	1.13	3.59	3.09	5.48	6.11
Quick Ratio	0.78	0.78	2.94	2.77	5.44	--
Interest Coverage	-106.11	-73.31	-53.86	-38.11	-21.81	-861.64

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	17.54	18.90	46.85	136.49	35.42	82.63
Asset Turnover	0.52	0.63	0.39	0.04	0.08	0.06
Receivable days	--	99.81	111.79	424.23	191.28	302.68
Inventory Days	--	154.54	282.41	1,550.88	3,558.58	--
Payable days	--	62.64	100.85	1,802.89	20,811.42	30.68
Cash Conversion Cycle	--	191.70	293.35	172.23	-17,061.57	272.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.